Published in J Physiol on December 06, 2010
Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity. Physiol Rev (2015) 1.10
Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci (2013) 1.01
The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions. Front Endocrinol (Lausanne) (2013) 0.87
CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans. Sleep (2012) 0.86
Differential distribution of glycine receptor subtypes at the rat calyx of Held synapse. J Neurosci (2012) 0.83
Orexin neurons receive glycinergic innervations. PLoS One (2011) 0.81
The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology (2014) 0.78
Hypothalamus proteomics from mouse models with obesity and anorexia reveals therapeutic targets of appetite regulation. Nutr Diabetes (2016) 0.75
The glutamate receptor ion channels. Pharmacol Rev (1999) 15.06
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
Reporting ethical matters in the Journal of Physiology: standards and advice. J Physiol (2009) 10.92
Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci (1998) 9.88
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32
Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature (2007) 8.22
The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature (1999) 7.66
Reduced number of hypocretin neurons in human narcolepsy. Neuron (2000) 6.94
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron (2001) 5.09
GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev (2007) 4.77
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci (2007) 4.46
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron (2005) 4.03
Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron (2003) 3.61
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05
Widespread expression of glycine receptor subunit mRNAs in the adult and developing rat brain. EMBO J (1991) 2.54
Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron (2006) 2.53
The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. EMBO J (1992) 2.38
Inhibitory of glycine on spinal neurons in the cat. J Neurophysiol (1968) 2.17
Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron (2002) 2.08
Control of hypothalamic orexin neurons by acid and CO2. Proc Natl Acad Sci U S A (2007) 1.99
Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes. EMBO J (1990) 1.98
Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse. Nature (2001) 1.94
Influence of dietary deprivations on plasma concentration of free amino acids of man. J Appl Physiol (1968) 1.72
Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation. EMBO J (1992) 1.60
Nonsynaptic glycine receptor activation during early neocortical development. Neuron (1998) 1.48
The glycine receptor. Pharmacol Ther (1997) 1.44
Identification and functional expression of a novel ligand binding subunit of the inhibitory glycine receptor. J Biol Chem (1990) 1.43
Excitatory actions of GABA in the suprachiasmatic nucleus. J Neurosci (2008) 1.41
Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci (2004) 1.35
Glycine and glycine receptor immunoreactivity in brain and spinal cord. J Neurosci (1988) 1.32
Presynaptic glycine receptors on GABAergic terminals facilitate discharge of dopaminergic neurons in ventral tegmental area. J Neurosci (2004) 1.29
Junctional versus extrajunctional glycine and GABA(A) receptor-mediated IPSCs in identified lamina I neurons of the adult rat spinal cord. J Neurosci (1999) 1.29
Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J Physiol (2002) 1.29
Reciprocal developmental regulation of presynaptic ionotropic receptors. Proc Natl Acad Sci U S A (2002) 1.27
Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices. J Neurophysiol (2002) 1.23
Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes. J Physiol (1998) 1.20
Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J Physiol (1997) 1.20
Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem Biophys Res Commun (2003) 1.19
Adaptive sugar sensors in hypothalamic feeding circuits. Proc Natl Acad Sci U S A (2008) 1.18
Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain. Neuroscience (1996) 1.17
GABAergic and glycinergic IPSCs in ganglion cells of rat retinal slices. J Neurosci (1997) 1.14
The time course of transmitter at glycinergic synapses onto motoneurons. J Neurosci (2008) 1.14
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol (2007) 1.13
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. Nat Neurosci (2005) 1.12
Glycinergic synaptic currents in Golgi cells of the rat cerebellum. Proc Natl Acad Sci U S A (1995) 1.11
Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res (2005) 1.09
Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neurobiol (2000) 1.07
GABA, not glutamate, a primary transmitter driving action potentials in developing hypothalamic neurons. J Neurophysiol (2001) 1.04
Glycine uptake regulates hippocampal network activity via glycine receptor-mediated tonic inhibition. Neuropsychopharmacology (2007) 1.03
Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors. Anesthesiology (2009) 0.99
Characteristics of inhibitory post-synaptic currents in brain-stem neurones of the lamprey. J Physiol (1983) 0.99
Functional glycine receptor maturation in the absence of glycinergic input in dopaminergic neurones of the rat substantia nigra. J Physiol (2002) 0.98
I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience (2008) 0.98
Activation of presynaptic glycine receptors facilitates glycine release from presynaptic terminals synapsing onto rat spinal sacral dorsal commissural nucleus neurons. J Physiol (2003) 0.94
Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine. J Neurosci (2001) 0.92
Presynaptic glycine receptors facilitate spontaneous glutamate release onto hilar neurons in the rat hippocampus. J Neurochem (2009) 0.90
Presynaptic glycine receptors on hippocampal mossy fibers. Biochem Biophys Res Commun (2010) 0.89
Strychnine-sensitive glycine responses in neurons of the lateral amygdala: an electrophysiological and immunocytochemical characterization. Neuroscience (1998) 0.88
Alpha2 subunit specificity of cyclothiazide inhibition on glycine receptors. Mol Pharmacol (2007) 0.83
Membrane properties underlying patterns of GABA-dependent action potentials in developing mouse hypothalamic neurons. J Neurophysiol (2001) 0.82
Extrasynaptic localization of glycine receptors in the rat supraoptic nucleus: further evidence for their involvement in glia-to-neuron communication. Neuroscience (2005) 0.80
Reciprocal connections between the lateral hypothalamus and the frontal complex in the rat: electrophysiological and anatomical observations. Brain Res (1981) 0.78
An intragastric amino acid mixture influences extracellular amino acid profiles in the lateral hypothalamic area of freely moving rats. Can J Physiol Pharmacol (1999) 0.77
Evidence for a glycinergic cortico-lateral hypothalamic inhibitory pathway in the rat. Brain Res (1982) 0.77
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol (2007) 5.27
MHC class II proteins and disease: a structural perspective. Nat Rev Immunol (2006) 2.66
Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron (2006) 2.53
Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J Clin Invest (2006) 2.38
A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol (2002) 2.31
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med (2007) 2.28
Constitutively active Lck kinase in T cells drives antigen receptor signal transduction. Immunity (2010) 2.22
Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med (2008) 2.19
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol (2006) 2.11
Control of hypothalamic orexin neurons by acid and CO2. Proc Natl Acad Sci U S A (2007) 1.99
Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus. Nat Neurosci (2013) 1.89
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol (2009) 1.83
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain (2005) 1.79
Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature (2006) 1.75
The nature of molecular recognition by T cells. Nat Immunol (2003) 1.70
Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol (2002) 1.61
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A (2002) 1.55
Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med (2003) 1.52
T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity (2009) 1.50
Pathogenic CD8(+) T cells in multiple sclerosis. Ann Neurol (2009) 1.32
Dissociation between sensing and metabolism of glucose in sugar sensing neurones. J Physiol (2008) 1.31
Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A (2004) 1.29
Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J Neurosci (2012) 1.28
Metabolism-independent sugar sensing in central orexin neurons. Diabetes (2008) 1.21
Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron (2011) 1.18
Adaptive sugar sensors in hypothalamic feeding circuits. Proc Natl Acad Sci U S A (2008) 1.18
Autoimmunity's next top models. Nat Med (2012) 1.14
Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol (2010) 1.13
IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain. Am J Pathol (2011) 1.11
The value of animal models for drug development in multiple sclerosis. Brain (2006) 1.11
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain (2011) 1.05
Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med (2013) 1.04
Use of calcium channel blockers and Parkinson's disease. Am J Epidemiol (2012) 1.03
Electrical inhibition of identified anorexigenic POMC neurons by orexin/hypocretin. J Neurosci (2007) 1.03
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol (2004) 0.99
Lateral hypothalamic GAD65 neurons are spontaneously firing and distinct from orexin- and melanin-concentrating hormone neurons. J Physiol (2012) 0.99
Deletion of TASK1 and TASK3 channels disrupts intrinsic excitability but does not abolish glucose or pH responses of orexin/hypocretin neurons. Eur J Neurosci (2009) 0.98
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology (2011) 0.96
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci U S A (2012) 0.96
MHC II molecules in inflammatory diseases: interplay of qualities and quantities. Trends Immunol (2005) 0.95
Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules. J Immunol (2006) 0.95
APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon. PLoS Genet (2012) 0.95
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. J Clin Invest (2002) 0.95
Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med (2008) 0.94
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J Immunol (2009) 0.93
Humanized mouse models for organ-specific autoimmune diseases. Curr Opin Immunol (2006) 0.93
Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock. J Neurosci (2014) 0.92
Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J Immunol (2004) 0.91
Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis. Acta Crystallogr D Biol Crystallogr (2011) 0.90
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain (2013) 0.90
The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN. J Am Soc Nephrol (2013) 0.89
Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels. J Physiol (2011) 0.89
Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci (2012) 0.88
5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated. J Neurosci (2013) 0.88
Natural killer cells and their receptors in multiple sclerosis. Brain (2012) 0.87
Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG. Blood (2011) 0.87
Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor. J Immunol (2008) 0.86
Glutamate and GABA as rapid effectors of hypothalamic "peptidergic" neurons. Front Behav Neurosci (2012) 0.86
Optogenetics: potentials for addiction research. Addict Biol (2011) 0.86
5-HT obesity medication efficacy via POMC activation is maintained during aging. Endocrinology (2014) 0.84
Dichotomous cellular properties of mouse orexin/hypocretin neurons. J Physiol (2011) 0.84
T cells and microglia as drivers of multiple sclerosis pathology. Brain (2007) 0.83
Paradoxical function of orexin/hypocretin circuits in a mouse model of Huntington's disease. Neurobiol Dis (2011) 0.82
Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J Neuroimmunol (2006) 0.81
Efficient purification of unique antibodies using peptide affinity-matrix columns. J Immunol Methods (2004) 0.81
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus. J Infect Dis (2003) 0.80
Silencing of ventromedial hypothalamic neurons by glucose-stimulated K(+) currents. Pflugers Arch (2009) 0.80
Longitudinal and cross-sectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract. Eur J Obstet Gynecol Reprod Biol (2004) 0.80
Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis. Immunol Rev (2012) 0.80
Stimulation of orexin/hypocretin neurones by thyrotropin-releasing hormone. J Physiol (2009) 0.79
An alternative conformation of the T-cell receptor alpha constant region. J Mol Biol (2010) 0.79
Tuning low-voltage-activated A-current for silent gain modulation. Neural Comput (2012) 0.78
Dissection of the multiple sclerosis associated DR2 haplotype. J Autoimmun (2008) 0.78
Weighing in on autoimmune disease: Big data tip the scale. Nat Med (2013) 0.77
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis. Pharmacogenomics (2013) 0.76
Multiple sclerosis: MHC associations and therapeutic implications. Expert Rev Mol Med (2005) 0.76
Unraveling electrical signaling strategies in hypothalamic feeding circuits. Trends Endocrinol Metab (2005) 0.76
Axonal injury in reverse. Nat Med (2011) 0.75